{"transactions":[{"id":681808,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":21765,"kind":"person","name":"Tardiff Daniel","position":1,"cik":"0002089301","reported_name":"Tardiff Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-20T00:46:05.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":1738,"price":4.76,"value":8272.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares sold were previously acquired by the reporting person pursuant to the CAMP4 Therapeutics Corporation Employee Stock Purchase Plan (the \"ESPP\") for the purchase period of January 1, 2026 through June 30, 2026 in a transaction that was exempt under Rule 16b-3(c)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-26-058107","document":"wk-form4_1787186763.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2089301/000162828026058107/wk-form4_1787186763.xml","form_type":"4"}},{"id":817256,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":21765,"kind":"person","name":"Tardiff Daniel","position":1,"cik":"0002089301","reported_name":"Tardiff Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:48:21.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant."}],"balance_after":170000,"derivative":{"exercise_price":4.46,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0002089301-26-000003","document":"wk-form4_1775249299.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2089301/000208930126000003/wk-form4_1775249299.xml","form_type":"4"}},{"id":961302,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":21765,"kind":"person","name":"Tardiff Daniel","position":1,"cik":"0002089301","reported_name":"Tardiff Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-22T22:42:07.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":145500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option has a vesting start date of December 1, 2025 and vests as to one third (33.33%) of the shares subject to the option on the first anniversary of the vesting start date and as to the remaining shares in equal monthly installments over 24 months thereafter, subject to continued service."}],"balance_after":145500,"derivative":{"exercise_price":6.01,"expiration_date":"2035-12-10","underlying":"Common Stock","underlying_shares":145500},"source":{"system":"sec-edgar","filing":"0002089301-25-000004","document":"wk-form4_1766443325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2089301/000208930125000004/wk-form4_1766443325.xml","form_type":"4"}}]}